Metro Healthcare Bhd (XKLS:0329) Current Deferred Revenue: RM0.00 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKLS:0329 Metro Healthcare Bhd XKLS:0329
61 GF Score
Price RM0.21
GF Value RM0.31
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Metro Healthcare Bhd Current Deferred Revenue?

Metro Healthcare Bhd XKLS:0329 -2.33% 61 Current Deferred Revenue is RM0.00 Mil as of Mar. 2026. GuruFocus rates XKLS:0329 with a GF Score™ of 61/100 and a GF Value™ of RM0.31 (Possible Value Trap). The stock has 4 warning signs investors should review.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Metro Healthcare Bhd's current deferred revenue for the quarter that ended in Mar. 2026 was RM0.00 Mil.

Metro Healthcare Bhd Current Deferred Revenue Related Terms


Metro Healthcare Bhd Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Metro Healthcare Bhd's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Metro Healthcare Bhd Current Deferred Revenue Chart

Metro Healthcare Bhd Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Metro Healthcare Bhd Quarterly Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XKLS:0329
61GF Score
Metro Healthcare Bhd XKLS:0329
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of RM0.00 Mil mean?
Metro Healthcare Bhd (XKLS:0329) has a Current Deferred Revenue of RM0.00 Mil as of Mar. 2026. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Metro Healthcare Bhd and its competitors.
Is Metro Healthcare Bhd's Current Deferred Revenue too high?
Metro Healthcare Bhd's current Current Deferred Revenue is RM0.00 Mil. Overall, Metro Healthcare Bhd has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Metro Healthcare Bhd's Current Deferred Revenue compare to HCA and THC?
Metro Healthcare Bhd's Current Deferred Revenue of RM0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Healthcare Providers & Services company?
A good Current Deferred Revenue depends on the Healthcare Providers & Services industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Metro Healthcare Bhd and its competitors. Metro Healthcare Bhd's current Current Deferred Revenue is RM0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Metro Healthcare Bhd stock overvalued right now?
Based on GuruFocus' analysis, Metro Healthcare Bhd (XKLS:0329) is currently considered Possible Value Trap. The stock's GF Value™ is RM0.31, compared to a current price of RM0.21 — trading 32.3% below its estimated fair value. The current Current Deferred Revenue is RM0.00 Mil. Metro Healthcare Bhd's overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For Metro Healthcare Bhd (XKLS:0329), the current Current Deferred Revenue is RM0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Metro Healthcare Bhd (XKLS:0329) Overvalued in 2026?

Based on GuruFocus' analysis, Metro Healthcare Bhd stock appears to be undervalued. The current stock price of RM0.21 is trading 32.3% below its estimated GF Value™ of RM0.31. GuruFocus considers Metro Healthcare Bhd to be Possible Value Trap.

Key valuation signals for XKLS:0329:

  • Current Deferred Revenue: RM0.00 Mil
  • GF Value™: RM0.31 vs. price of RM0.21 (32.3% below fair value)
  • GF Score™: 61/100 with 4 warning signs

No single metric tells the full story. See the XKLS:0329 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Metro Healthcare Bhd Business Description

Address No. 32, Jalan Pasar, Klang, SGR, MYS, 41400
Metro Healthcare Bhd is engaged in the provision of women healthcare services. The company offers various services such as obstetrics, gynecology impatient services, and diagnostic medical imaging services. It also provides semen analysis, intracytoplasmic sperm injection, blastocyst culture, assisted hatching, frozen embryo transfer, preimplantation genetic screening, and infertility consultation services. The company serves patients in Malaysia. The firm's business segment includes O&G healthcare services, Complementary services, and Hospital services.
61GF Score

Get the complete analysis for XKLS:0329

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.21
Price
RM0.31
GF Value